In the last years, the incidence of Candida infections in liver transplant recipients has increased with still higher morbidity and mortality. Anidulafungin, a new echinocandin that does not interfere with cytochrome p450, shows no need for dosage adjustment based upon renal or hepatic function or weight.
Sganga, G., Pepe, G., Cozza, V., Nure, E., Lirosi, M. C., Frongillo, F., Grossi, U., Bianco, G., Agnes, S., Anidulafungin--a new therapeutic option for Candida infections in liver transplantation, <<TRANSPLANTATION PROCEEDINGS>>, 2012; 44 (7): 1982-1985. [doi:10.1016/j.transproceed.2012.06.029] [http://hdl.handle.net/10807/40542]
Anidulafungin--a new therapeutic option for Candida infections in liver transplantation
Sganga, Gabriele;Pepe, Gilda;Nure, Erida;Lirosi, Maria Carmen;Frongillo, Francesco;Grossi, Ugo;Bianco, Giuseppe;Agnes, Salvatore
2012
Abstract
In the last years, the incidence of Candida infections in liver transplant recipients has increased with still higher morbidity and mortality. Anidulafungin, a new echinocandin that does not interfere with cytochrome p450, shows no need for dosage adjustment based upon renal or hepatic function or weight.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
